Edap Tms S.A. (NASDAQ:EDAP – Get Free Report)’s stock price crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $6.11 and traded as high as $7.57. Edap Tms shares last traded at $7.26, with a volume of 8,829 shares traded.
Wall Street Analyst Weigh In
Separately, StockNews.com lowered shares of Edap Tms from a “hold” rating to a “sell” rating in a research note on Tuesday, February 13th.
Check Out Our Latest Report on EDAP
Edap Tms Stock Performance
Hedge Funds Weigh In On Edap Tms
Institutional investors and hedge funds have recently made changes to their positions in the stock. Cetera Advisor Networks LLC increased its stake in Edap Tms by 0.9% in the fourth quarter. Cetera Advisor Networks LLC now owns 111,162 shares of the medical equipment provider’s stock valued at $1,185,000 after purchasing an additional 944 shares during the last quarter. Quadrant Capital Group LLC grew its position in shares of Edap Tms by 337.7% in the 2nd quarter. Quadrant Capital Group LLC now owns 3,642 shares of the medical equipment provider’s stock valued at $34,000 after buying an additional 2,810 shares during the last quarter. BlackRock Inc. grew its position in shares of Edap Tms by 27.3% in the 1st quarter. BlackRock Inc. now owns 13,527 shares of the medical equipment provider’s stock valued at $150,000 after buying an additional 2,898 shares during the last quarter. Envestnet Asset Management Inc. grew its position in shares of Edap Tms by 24.6% in the 3rd quarter. Envestnet Asset Management Inc. now owns 14,736 shares of the medical equipment provider’s stock valued at $122,000 after buying an additional 2,911 shares during the last quarter. Finally, Commonwealth Equity Services LLC grew its position in shares of Edap Tms by 5.3% in the 1st quarter. Commonwealth Equity Services LLC now owns 65,135 shares of the medical equipment provider’s stock valued at $721,000 after buying an additional 3,250 shares during the last quarter. 43.56% of the stock is owned by institutional investors and hedge funds.
Edap Tms Company Profile
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST).
See Also
- Five stocks we like better than Edap Tms
- What is the Euro STOXX 50 Index?
- Walmart: Here’s Your Chance to Get in Cheaper in 2024
- What Makes a Stock a Good Dividend Stock?
- Insider Selling of Amazon Spikes in Q1, but it’s Not Time to Sell
- What Is WallStreetBets and What Stocks Are They Targeting?
- 2 Deep Value, High Yield Stocks With a Double-Digit Upside
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.